Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.creator | Goossens, G.H. (Gijs H.) | - |
dc.creator | Dicker, D. (Dror) | - |
dc.creator | Farpour-Lambert, N. (Nathalie) | - |
dc.creator | Frühbeck, G. (Gema) | - |
dc.creator | Mullerova, D. (Dana) | - |
dc.creator | Woodward, E. (Euan) | - |
dc.creator | Holm, J.C. (Jens-Christian) | - |
dc.date.accessioned | 2023-08-31T08:39:36Z | - |
dc.date.available | 2023-08-31T08:39:36Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Goossens, G.H. (Gijs H.); Dicker, D. (Dror); Farpour-Lambert, N. (Nathalie); et al. "Obesity and COVID-19: A perspective from the european association for the study of obesity on immunological perturbations, therapeutic challenges, and opportunities in obesity". Obesity facts. 13 (4), 2020, 439 - 452 | es |
dc.identifier.issn | 1662-4025 | - |
dc.identifier.uri | https://hdl.handle.net/10171/67198 | - |
dc.description.abstract | Accumulating evidence suggests that obesity is a major risk factor for the initiation, progression, and outcomes of coronavirus disease 2019 (COVID-19). The European Association for the Study of Obesity (EASO), as a scientific and medical society dedicated to the promotion of health and well-being, is greatly concerned about the concomitant obesity and COVID-19 pandemics and their impact on health and society at large. In this perspective, we will address the inherent immunological perturbations and alterations in the renin-angiotensin-aldosterone system in patients with obesity and COVID-19, and discuss how these impairments may underlie the increased susceptibility and more detrimental outcomes of COVID-19 in people with obesity. Clearly, this has important implications for preventive measures, vaccination, and future therapeutic strategies to combat COVID-19. Furthermore, we will highlight important knowledge gaps and provide suggestions for future research and recommendations for policy actions. Since many new reports on COVID-19 rapidly appear, the present perspective should be seen as a focus for discussion to drive forward further understanding, research initiatives, and clinical management of COVID-19. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Karger | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Severe acute respiratory syndrome coronavirus 2 | es_ES |
dc.subject | SARS-CoV-2 | es_ES |
dc.subject | ACE2 | es_ES |
dc.subject | Coronavirus disease 2019 | es_ES |
dc.subject | COVID-19 | es_ES |
dc.subject | Obesity | es_ES |
dc.subject | Renin-angiotensin-aldosterone system | es_ES |
dc.subject | Immune response | es_ES |
dc.title | Obesity and COVID-19: A perspective from the european association for the study of obesity on immunological perturbations, therapeutic challenges, and opportunities in obesity | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.description.note | This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. | es_ES |
dc.identifier.doi | 10.1159/000510719 | - |
dadun.citation.endingPage | 452 | es_ES |
dadun.citation.number | 4 | es_ES |
dadun.citation.publicationName | Obesity facts | es_ES |
dadun.citation.startingPage | 439 | es_ES |
dadun.citation.volume | 13 | es_ES |
dc.identifier.pmid | 32791497 | - |
Ficheros en este ítem:
Estadísticas e impacto
Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.